Table 2 List of simulated systems.

From: N-Glycosylation can selectively block or foster different receptor–ligand binding modes

System

Glycoform

HA

FF

Length (ns)

DOI data

G1\(^{\rm{a}}\)

Myeloma asialo

None

GLYCAM06

\(\text {3}\times \text {5}\times \text {1000}\)

10.5281/zenodo.3742147

G2\(^{\rm{a}}\)

Myeloma monosialo

None

GLYCAM06

\(\text {3}\times \text {5}\times \text {1000}\)

10.5281/zenodo.3742149

G3\(^{\rm{a,b}}\)

Partial monosialo

None

GLYCAM06

\(\text {3}\times \text {5}\times \text {1000}\)

10.5281/zenodo.3742154

G4

Full pentasaccharide

None

GLYCAM06

\(\text {3}\times \text {5}\times \text {1000}\)

10.5281/zenodo.3742158

B1\(^{\rm{e}}\)

Non-glycosylated

\(\hbox {HA}_{{18}}\)

GLYCAM06

\(8 \times 1000\)

10.5281/zenodo.4005682

B2\(^{\rm{f}}\)

Full GlcNAc

\(\hbox {HA}_{{18}}\)

GLYCAM06

\(8 \times 1000\)

10.5281/zenodo.4005689

B3\(^{\rm{c,d,g}}\)

Full asialo

\(\hbox {HA}_{{18}}\)

GLYCAM06

\(8 \times 1000\)

10.5281/zenodo.4005691

B4\(^{\rm{d,f}}\)

Full monosialo

\(\hbox {HA}_{{18}}\)

GLYCAM06

\(8 \times 1000\)

10.5281/zenodo.4005695

B5\(^{\rm{b}}\)

Partial monosialo

\(\hbox {HA}_{{18}}\)

GLYCAM06

\(8 \times 1000\)

10.5281/zenodo.4005701

B6\(^{\rm{f}}\)

Full polysialo

\(\hbox {HA}_{{18}}\)

GLYCAM06

\(8 \times 1000\)

10.5281/zenodo.4005707

B7

Full extended asialo

\(\hbox {HA}_{{18}}\)

GLYCAM06

\(8 \times 1000\)

10.5281/zenodo.4005740

B8

Full pentasaccharide

\(\hbox {HA}_{{18}}\)

GLYCAM06

\(8 \times 1000\)

10.5281/zenodo.4005743

C1\(^{\rm{a,c,d}}\)

Myeloma asialo

\(\hbox {HA}_{{18}}\)

CHARMM36

\(\text {3} \times \text {1000}\)

10.5281/zenodo.3742175

C2\(^{\rm{a,c,d}}\)

Myeloma monosialo

\(\hbox {HA}_{{18}}\)

CHARMM36

\(\text {3} \times \text {1000}\)

10.5281/zenodo.3742177

G5

Non-glycosylated

\(\hbox {HA}_{{6}}\)

GLYCAM06

\(\text {20} \times \text {1000}\)

10.5281/zenodo.3742160

G6

Non-glycosylated

\(\hbox {HA}_{{6}}\)

GLYCAM06

\(\text {10} \times \text {1000}\)

10.5281/zenodo.3742167

  1. Glycoform tells the N-glycan content on the CD44 HABD in each system. HA tells whether HA was present and which kind. FF lists the simulation force field. Length lists the duration of the simulations. Glycoforms of CD44 were experimentally found in: \(^{\rm{a}}\)Ref.26, \(^{\rm{b}}\)Ref.19, \(^{\rm{c}}\)Ref.9, \(^{\rm{d}}\)Ref.18, \(^{\rm{e}}\)Ref.24, \(^{\rm{f}}\)Ref.16, and \(^{\rm{g}}\)Ref.17.